The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Pre Transplantation Melanoma
Official Title: Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study
Study ID: NCT04217382
Brief Summary: Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma. There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet. Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
service de dermatologie - hopital Edouard Herriot, Lyon, Rhone, France
Name: Emilie DUCROUX, MD
Affiliation: Service de Dermatologie, Hôpital Edouard Herriot, Lyon
Role: PRINCIPAL_INVESTIGATOR